Back on track

Update | Financials | 18/04/2019

Subdued FY18 results reflect market trends

Update | Financials | 18/04/2019

Fuelling up for growth

Flash note | Aerospace & Defence | 18/04/2019

Wipac costs higher than expected in Q419

Update | Technology | 18/04/2019

Looking forward to Treakisym Phase III data

ADR Outlook | Pharmaceuticals & healthcare | 18/04/2019

Goal of doubling installed base achieved

Update | Industrial Support Services | 18/04/2019

Tough FY19, dividends rebased

Update | General Industrials | 18/04/2019

Strong Q1 revenues and orders

Flash note | Technology | 17/04/2019

A change of pace with three new clinical trials

Update | Pharmaceuticals & healthcare | 17/04/2019

Increased marketing to drive revenue growth

Update | Technology | 17/04/2019

Cash-generation engine powers onwards

Outlook | Technology | 17/04/2019

First revenue-generating agreement

Flash note | General Industrials | 17/04/2019

International expansion drives strong H2

Update | Technology | 17/04/2019

Looking forward to Treakisym Phase III data

Outlook | Pharmaceuticals & healthcare | 17/04/2019

Marching on up

Update | Consumer Support Services | 17/04/2019

Increasing iron ore royalties supporting Mardie

Update | Mining | 16/04/2019

NAV and forecast update - South Disouq delays

Update | Oil & gas | 16/04/2019

Commercial revenues in 2020

Update | General Industrials | 16/04/2019

Structural strength

Update | Technology | 16/04/2019

Investing in Evofem

Update | Pharmaceuticals & healthcare | 16/04/2019

Company de-risked and metrics improved

Update | Mining | 16/04/2019

Market to enable further growth

Outlook | General Industrials | 16/04/2019

Trust worthy

Initiation | Technology | 16/04/2019

Delivering on its strategy

Update | General Industrials | 15/04/2019

Building the business for a brighter future

Update | Technology | 15/04/2019

Rapid and effective diagnosis of infection

Initiation | Pharmaceuticals & healthcare | 15/04/2019

Unloved small-caps offer long-term opportunities

Review | Investment trusts | 15/04/2019

On track to reach our FY19 growth forecast

Update | General Industrials | 15/04/2019

HER-Vaxx Phase II underway

Update | Pharmaceuticals & healthcare | 15/04/2019

Q1 book-to-bill of 1.16x

Update | Technology | 15/04/2019

Cash flow miner, growth generator

Initiation | General Industrials | 15/04/2019

Diversification supports profits growth

Update | Consumer staples | 15/04/2019

Full-year financial results

Update | Pharmaceuticals & healthcare | 15/04/2019

Sounds like a good deal

Flash note | Media | 12/04/2019

A guiding hand for advertisers

Outlook | Media | 12/04/2019

Compliant digital solutions

Update | Media | 12/04/2019

Alvarrões resource increases 290%

Update | Mining | 12/04/2019

Prima gearing up for a pivotal year

Outlook | Pharmaceuticals & healthcare | 12/04/2019

Post-acquisition valuation update

Update | Oil & gas | 12/04/2019

Compliant digital solutions

Update | Media | 11/04/2019

Long-awaited partnering floodgates open

Update | Pharmaceuticals & healthcare | 11/04/2019

Confident outlook

Update | Technology | 11/04/2019

Rapid acceleration in the US market

Outlook | Pharmaceuticals & healthcare | 11/04/2019

Margins to expand with scale and growth

Outlook | Technology | 11/04/2019

Creating value through asset management

Update | Property | 11/04/2019

Well-funded with clinical results in a year

Update | Pharmaceuticals & healthcare | 11/04/2019

Counter-cyclical investment strengthens the group

Update | Financials | 11/04/2019

A scale platform for further growth

Outlook | Property | 10/04/2019

On a mission

Initiation | Consumer Support Services | 10/04/2019

Achieving superior returns from alternative assets

Review | Investment trusts | 09/04/2019

A new regulatory strategy for dovitinib

Update | Pharmaceuticals & healthcare | 09/04/2019

Earnings growth undervalued

Update | Industrial Support Services | 09/04/2019

Better visibility

Update | Technology | 09/04/2019

Another year of progress

QuickView | Media | 09/04/2019

US customer supports substantial revenue growth

Update | Technology | 09/04/2019

Encouraging results for efti and IMP761

ADR Update | Pharmaceuticals & healthcare | 08/04/2019

Encouraging results for efti and IMP761

Update | Pharmaceuticals & healthcare | 08/04/2019

Services and oncology businesses to split

Update | Pharmaceuticals & healthcare | 08/04/2019

Dazzling

Initiation | Mining | 08/04/2019

Another positive half

Update | Basic Industries | 05/04/2019

FY18 results beat our estimates, forecasts raised

Update | General Industrials | 05/04/2019

Adjusting to prevailing conditions

Outlook | Financials | 04/04/2019

New funds allow progress of key trials

Update | Pharmaceuticals & healthcare | 04/04/2019

New name, same tried-and-tested approach

Review | Investment trusts | 04/04/2019

Exponential increases in speeds widen market

QuickView | Technology | 04/04/2019

Good year all round

Update | Media | 04/04/2019

Guidance: Odor-No-More break-even by YE19

QuickView | Pharmaceuticals & healthcare | 04/04/2019

Focus shifting to drilling ahead of EPS first oil

Update | Oil & gas | 04/04/2019

Next step US Feraccru approval

Update | Pharmaceuticals & healthcare | 03/04/2019

Plenty of attractive investment opportunities

Review | Investment trusts | 03/04/2019

Disposal of non-core eye-screening business

Update | Technology | 03/04/2019

Executing on China rollout

Update | Pharmaceuticals & healthcare | 03/04/2019

New business growth and changes to ZZR

Update | Financials | 03/04/2019

All the bases loaded for ASIT011

Update | Pharmaceuticals & healthcare | 03/04/2019

Prostate programmes boosted

Outlook | Pharmaceuticals & healthcare | 03/04/2019

Calendar 2018 drought affects profits

Update | General Industrials | 02/04/2019

Return to growth

Update | General Industrials | 02/04/2019

Tax stamp deals underpin PA&T growth

Flash note | Industrial Support Services | 02/04/2019

Tough H1 background but strong market share gains

Update | Financials | 02/04/2019

Short-term profits hit for future gain

Update | Technology | 02/04/2019

Premium positioning

Outlook | General Industrials | 02/04/2019

Entering a restructuring phase

Flash note | Financials | 02/04/2019

Activated data

Update | Media | 02/04/2019

Positive and ready for growth

Update | Financials | 01/04/2019

Ity CIL project pours first gold

Update | Mining | 01/04/2019

Contract win in China

Flash note | Technology | 01/04/2019

Cantrixil efficacy data presented at AACR

ADR Update | Pharmaceuticals & healthcare | 01/04/2019

Near-term EU sedation filing added to the list

Update | Pharmaceuticals & healthcare | 01/04/2019

Kunning

Outlook | Mining | 01/04/2019

Cantrixil efficacy data presented at AACR

Update | Pharmaceuticals & healthcare | 01/04/2019

All set for an eventful 2019

Update | Pharmaceuticals & healthcare | 01/04/2019

Navigating through tough times

Update | Food & Drink | 29/03/2019

A record quarter; continued high dividends

Update | Technology | 29/03/2019

An attractive dividend yield with growth

Update | General Industrials | 29/03/2019

Outlook is ‘very encouraging’

Update | Technology | 28/03/2019

Recurring revenue jumps 48%

Update | Technology | 28/03/2019

Accelerating growth in new contracts

Update | Technology | 28/03/2019

Moving towards R&D inflection points

Outlook | Pharmaceuticals & healthcare | 28/03/2019

Evidence that investment is paying off

Update | Financials | 28/03/2019

Rounding out a productive year of R&D

Update | Pharmaceuticals & healthcare | 28/03/2019